Cargando…
Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front
Reduction of epithelial cell–cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial–mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, cancer invasion and recurre...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2522326/ https://www.ncbi.nlm.nih.gov/pubmed/18648847 http://dx.doi.org/10.1007/s00418-008-0464-1 |
_version_ | 1782158650827079680 |
---|---|
author | De Wever, Olivier Pauwels, Patrick De Craene, Bram Sabbah, Michèle Emami, Shahin Redeuilh, Gérard Gespach, Christian Bracke, Marc Berx, Geert |
author_facet | De Wever, Olivier Pauwels, Patrick De Craene, Bram Sabbah, Michèle Emami, Shahin Redeuilh, Gérard Gespach, Christian Bracke, Marc Berx, Geert |
author_sort | De Wever, Olivier |
collection | PubMed |
description | Reduction of epithelial cell–cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial–mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, cancer invasion and recurrence. Furthermore, the tumor stroma dictates EMT through intensive bidirectional communication. The pathological analysis of EMT signatures is critically, especially to determine the presence of cancer cells at the resection margins of a tumor. When diffusion barriers disappear, EMT markers may be detected in sera from cancer patients. The detection of EMT signatures is not only important for diagnosis but can also be exploited to enhance classical chemotherapy treatments. In conclusion, further detailed understanding of the contextual cues and molecular mediators that control EMT will be required in order to develop diagnostic tools and small molecule inhibitors with potential clinical implications. |
format | Text |
id | pubmed-2522326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-25223262008-08-27 Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front De Wever, Olivier Pauwels, Patrick De Craene, Bram Sabbah, Michèle Emami, Shahin Redeuilh, Gérard Gespach, Christian Bracke, Marc Berx, Geert Histochem Cell Biol Review Reduction of epithelial cell–cell adhesion via the transcriptional repression of cadherins in combination with the acquisition of mesenchymal properties are key determinants of epithelial–mesenchymal transition (EMT). EMT is associated with early stages of carcinogenesis, cancer invasion and recurrence. Furthermore, the tumor stroma dictates EMT through intensive bidirectional communication. The pathological analysis of EMT signatures is critically, especially to determine the presence of cancer cells at the resection margins of a tumor. When diffusion barriers disappear, EMT markers may be detected in sera from cancer patients. The detection of EMT signatures is not only important for diagnosis but can also be exploited to enhance classical chemotherapy treatments. In conclusion, further detailed understanding of the contextual cues and molecular mediators that control EMT will be required in order to develop diagnostic tools and small molecule inhibitors with potential clinical implications. Springer-Verlag 2008-07-22 2008-09 /pmc/articles/PMC2522326/ /pubmed/18648847 http://dx.doi.org/10.1007/s00418-008-0464-1 Text en © Springer-Verlag 2008 |
spellingShingle | Review De Wever, Olivier Pauwels, Patrick De Craene, Bram Sabbah, Michèle Emami, Shahin Redeuilh, Gérard Gespach, Christian Bracke, Marc Berx, Geert Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front |
title | Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front |
title_full | Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front |
title_fullStr | Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front |
title_full_unstemmed | Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front |
title_short | Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front |
title_sort | molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2522326/ https://www.ncbi.nlm.nih.gov/pubmed/18648847 http://dx.doi.org/10.1007/s00418-008-0464-1 |
work_keys_str_mv | AT deweverolivier molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT pauwelspatrick molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT decraenebram molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT sabbahmichele molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT emamishahin molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT redeuilhgerard molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT gespachchristian molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT brackemarc molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront AT berxgeert molecularandpathologicalsignaturesofepithelialmesenchymaltransitionsatthecancerinvasionfront |